FrieslandCampina Ingredients, Triplebar Bio Inc. Partner to Bring Cell-Based Proteins to Market Through Precision Fermentation
The partnership reaffirms a commitment from both companies to develop innovative and futureproof protein solutions that improve human health
FrieslandCampina Ingredients, a global innovator in healthy and functional ingredients, announced a strategic partnership with specialist biotechnology company Triplebar Bio Inc. to develop and scale up the production of cell-based proteins using precision fermentation. The partnership reaffirms the commitment of both companies to develop innovative and futureproof protein solutions that improve human health.
The world’s population is predicted to reach nearly 10 billion by 2050. This means more protein sources are needed to keep people healthy and active throughout all stages of life. With close to 100 years of experience in dairy protein processing, FrieslandCampina Ingredients uses its experience and expertise to develop much needed solutions to the world’s protein challenges with best-in-class nutritional value, taste and functionality. This latest partnership follows the company’s launch of its first plant protein range, Plantaris™, in partnership with AGT Foods in November 2021.
California-based biotechnology company Triplebar specializes in bioengineering at speed to develop solutions for the nutrition and healthcare industries. The company takes an integrated approach, using hardware, software, biology and biochemistry to develop products and biological production systems that replicate and accelerate evolution found in nature. FrieslandCampina Ingredients and Triplebar will produce microbial cells through precision fermentation that can create bioactive proteins that support human health and nutrition in early life and adulthood. The ambition of both companies is to manufacture high quality proteins for various applications at scale and with a limited land, water and energy footprint.
FrieslandCampina Ingredients has been using precision fermentation since 2016 to produce human milk oligosaccharides (HMOs). The company will leverage its unique combination of protein experience alongside its innovation, processing and technical expertise to produce highly nutritious, alternative protein solutions using the latest precision fermentation technology.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
